









Markets
/
Stocks
/
nasdaq-elab
/

PMGC Holdings Inc

ELAB

5.820USD

-0.280-4.59%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

8.60MMarket Cap

LossP/E TTM



PMGC Holdings Inc

5.820

-0.280-4.59%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

62 / 72

Overall Ranking

503 / 4720

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 246.93.

Overvalued

The company’s latest PE is 0.03, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 45.85K shares, decreasing 43.06% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.78K shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.72, which is lower than the Healthcare Providers & Services industry's average of 7.42. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.72

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.29

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.67

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.63

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.03

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 1.80, which is lower than the Healthcare Providers & Services industry's average of 2.34. Its current P/E ratio is 0.03, which is -24.08% below the recent high of 0.02 and 1240.13% above the recent low of -0.34.

Score

Industry at a Glance

Previous score

1.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 62/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 2.49, which is lower than the Healthcare Providers & Services industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 7.71 and the support level at 3.02, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.49

Change

-0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MACD(12,26,9)

0.330

Buy

RSI(14)

74.913

Buy

STOCH(KDJ)(9,3,3)

83.619

Overbought

ATR(14)

0.671

Low Volatility

CCI(14)

105.252

Buy

Williams %R

21.483

Buy

TRIX(12,20)

4.718

Buy

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

5.818

Buy

MA10

5.192

Buy

MA20

4.114

Buy

MA50

2.915

Buy

MA100

2.594

Buy

MA200

6.409

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

L1 Capital Global Opportunities Master Fund Ltd.

810.00

Geode Capital Management, L.L.C.

-100.00%

Sabby Management, LLC

38.46K

UBS Financial Services, Inc.

1.53K

+16.92%

BWL Investments Ltd

1.36K

-30.26%

Lichti (Braeden William Sinclair)

582.00

-1.52%

Tower Research Capital LLC

1.20K

+1998.25%

MOA Life Plus Co,Ltd.

679.00

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 2.92, which is lower than the Healthcare Providers & Services industry's average of 4.18. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.